Taxandria Advocatenkantoor
0837.064.666 · rovalta.com · 28/09/2026
Taxandria Advocatenkantoor
Financial year 2025 · Closed on 30/06/2025
Overview
Identity
Source · BCE/KBOTaxandria Advocatenkantoor is a Private limited company incorporated in 2011. Its main activity is: Legal activities. Its registered office is in Zoersel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0837.064.666
- Incorporation
- 16/06/2011
- Legal form
- Private limited company
- Registered office
- Oostmallebaan 87
2980 Zoersel · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 30/06/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 42,1 k € | -30.4% | 60,5 k € | -66.0% | 177,8 k € | +126% | 78,5 k € | +70.9% | 46 k € |
| EBITDA | 41,2 k € | -30.8% | 59,6 k € | -66.0% | 175,4 k € | +128% | 76,9 k € | +71.8% | 44,7 k € |
| Operating result | 36,1 k € | -33.4% | 54,2 k € | -68.2% | 170,3 k € | +133% | 73,2 k € | +89.1% | 38,7 k € |
| Net result | 31,2 k € | -22.9% | 40,5 k € | -68.9% | 130,2 k € | +140% | 54,2 k € | +95.3% | 27,8 k € |
| Balance sheet | |||||||||
| Equity | 217,7 k € | +16.7% | 186,5 k € | +27.7% | 146 k € | +823% | 15,8 k € | 0.0% | 15,8 k € |
| Total assets | 244,2 k € | -16.3% | 291,7 k € | +40.1% | 208,2 k € | +66.9% | 124,7 k € | +95.7% | 63,7 k € |
| Cash | 23,5 k € | +100% | 11,7 k € | -47.4% | 22,3 k € | +324% | 5,3 k € | -61.1% | 13,5 k € |
| Debts | 24,9 k € | -75.9% | 103,6 k € | +71.0% | 60,6 k € | -43.3% | 106,8 k € | +149% | 42,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bart Ameye | DirectorManagersince 17/06/2011ended |
Other companies at this address
Oostmallebaan 87 2980 Zoersel| Company | CBE no. |
|---|---|
Oblita Therapeutics● Active | 0832.102.424 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 18 months | 12 months |
| Filing date | 10/12/2025 | 03/12/2024 | 05/12/2023 | 15/12/2022 | 07/12/2021 | 26/03/2020 |
| General meeting | 01/12/2025 | 01/12/2024 | 01/12/2023 | 01/12/2022 | 01/12/2021 | 20/03/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 01/12/2025 | 10/12/2025 | Dutch | |
| Micro model | 30/06/2024 | 01/12/2024 | 03/12/2024 | Dutch | |
| Micro model | 30/06/2023 | 01/12/2023 | 05/12/2023 | Dutch | |
| Micro model | 30/06/2022 | 01/12/2022 | 15/12/2022 | Dutch | |
| Micro model | 30/06/2021 | 01/12/2021 | 07/12/2021 | Dutch | |
| Micro model | 31/12/2019 | 20/03/2020 | 26/03/2020 | Dutch | |
| Micro model | 31/12/2018 | 15/03/2019 | 02/04/2019 | Dutch | |
| Micro model | 31/12/2017 | 16/03/2018 | 12/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 17/03/2017 | 27/03/2018 | Dutch | |
| Abridged model | 31/12/2015 | 18/03/2016 | 29/08/2016 | Dutch | |
| Abridged model | 31/12/2014 | 20/03/2015 | 18/05/2016 | Dutch | |
| Abridged model | 31/12/2013 | 21/03/2014 | 16/06/2014 | Dutch | |
| Abridged model | 31/12/2012 | 15/03/2013 | 13/06/2013 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Bart Ameye | DirectorManagersince 17/06/2011ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office23/04/2021MAATSCHAPPELIJKE ZETEL
- Mandates21/12/2020WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
- Registered office24/12/2013BENAMING - MAATSCHAPPELIJKE ZETEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other29/06/2011RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Oostmallebaan 87, 2980 ZoerselCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00579351 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Taxandria AdvocatenkantoorCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00579351 |
Events
- 2025Annual accounts 202531,2 k €↓
- 2024Annual accounts 202440,5 k €↓
- 2023Annual accounts 2023130,2 k €↑
- 2022Annual accounts 202254,2 k €↑
- 2021Annual accounts 202127,8 k €↑
- 2019Annual accounts 2019344,8 €↓
- 2018Annual accounts 201815,5 k €↓
- 2017Annual accounts 201726,6 k €↑
- 2016Annual accounts 201610,8 k €↑
- 2015Annual accounts 2015-32,2 k €↑
- 2014Annual accounts 2014-43,2 k €↓
- 2013Annual accounts 201315,2 k €↑
- 2012Annual accounts 2012-17,4 k €
- 16/06/2011IncorporationPrivate limited company